Showing 1 - 1 results of 1 for search 'Fanlu Meng', query time: 0.01s Refine Results
  1. 1
    Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation

    Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation by Lingping Kong, Lina Peng, Xue Yang, Qing Ma, Linlin Zhang, Xia Liu, Diansheng Zhong, Fanlu Meng

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: